Dr. Darren Candow

I'd really like to look at some blood biomarkers, indication of what's happening from an inflammation perspective.

So there's a lot of work in that area to go.

Yeah.

Yes.

Yeah, yeah.

I always think of caffeine, the adenosine.

Right, right, right.

Yeah, no, it's possibly there.

There's been a lot of speculation.

They thought also glycine is implicated and where glycine is involved in the synthesis of creatine.

So there's a lot there.

I think we'll talk maybe about homocysteine a little bit later and the methyl.

So, God, there's a lot of areas to look at and...

I think we thought we knew everything about creatine, and now it's taken on a new life of its own.

And again, I'll have a jaw for maybe 20 or 30 more years looking at this.

Oh, yeah.

Yeah, we've looked at the totality of limited evidence, and we're not seeing a lot of effects yet.

There's benefits on young boys with muscular dystrophy, but that's a little bit different.

But when we look at ALS, Parkinson's, Huntington's, multiple sclerosis,

All those dementia and Alzheimer's, we're not seeing a lot of problems.